•Typical – e.g. chlorpromazine are dopamine antagonists – developed in the 1950’s - they bind to (and so block) dopamine receptors but don’t stimulate them, reducing the action of dopamine. Initially dopamine levels build up but then production is reduced. This normalises neurotransmission in key areas of the brain, by reducing stimulation of the dopamine system reducing positive symptoms such as hallucinations.